Objective-To assess the effect of high dose inhaled corticosteroids on skin.
Introduction
The introduction of inhaled corticosteroids revolutionised the treatment of bronchial asthma in the 1960s. ' High dose inhaled corticosteroids, either (table I) .
Skin thickness is related to both age and sex. ' '2 Change in skin thickness with age is small,'2 and furthermore there was good comparability for age between each patient group and the control group (table I) . Female skin is thinner than male skin by a factor of 0-8." All analyses were therefore performed after adjustment of the raw data for sex by using the correction factor: female skin thickness x 125= male skin thickness. All groups were well matched for sex, Five ultrasound measurements were taken from the dorsum of the right hand (a solar exposed site) and from the medial aspect of the upper right arm and the upper outer quadrant of the left buttock (both non-solar exposed sites). The individual mean value at each site was then calculated.
To account for the fact that we were carrying out repeated tests across three sites, only results significant at the 1% level were considered notable, hence maintaining an approximate overall 5% level of significance. To assess whether there was any difference among the groups a Kruskal-Wallis test was performed on all the data at each site. If this test result was significant then it remained to determine between which groups the differences were significant. The three steroid treated groups were to be compared with the control group, so that multiple comparisons were to be made. The non-parametric test chosen for this analysis was the Nemenyi extension of the Kruskal-Wallis ranking technique," which allows multiple comparisons among groups of different sizes. For this test the x2 approximation to the specified Treatment group Individual skin thicknesses over buttock in the four groups ofpatients. Horizontal and vertical bars are medians and 95% confidence intervals'" distribution function was made as sufficient data points were available.
Differences in the prevalences of purpura and striae were assessed by the X2 test with Yates's correction.
The purpura and striae scores were dichotomised into a group with a score of zero and a group with scores of 1 or more-that is, the presence or absence of these features was tested.
The study was approved by the local medical ethics committee, and witnessed and written informed consent was obtained from every patient.
Results
Table II summarises the skin thickness measurements of each group at each site investigated, and the figure shows the individual measurements over the buttock. Unless stated otherwise all results given below are significant at the 1% level.
In the group taking long term prednisolone skin thickness was substantially less than that in the control group at all sites (median thicknesses over hand, arm, and buttock 33%, 28%, and 32% less than in control group). In the group taking long term high dose inhaled corticosteroids skin thickness was also less than that in the control group at all sites (median thicknesses over hand, arm, and buttock 15%, 17%, and 19% less than in control group). In the group taking long term low dose inhaled corticosteroids no significant differences in skin thickness compared with control values were found at any site.
In the group taking long term high dose inhaled corticosteroids there was a negative correlation between duration of treatment and skin thickness which was significant at two of the three sites (hand: r5=-0 18, p=0-2; arm: r,=-0 37, p=0 01; buttock: r,=-0 42, p=0 004 (Spearman's rank correlation corrected for ties)).
The prevalence of purpura as noted by the clinician was lowest in the control group (2/17 patients) and increased across the low dose inhaled steroid (5/15), high dose inhaled steroid (10/21), and prednisolone treated groups (12/15 patients) (x2 for trend= 15 There was no evidence of any difference in the prevalence of striae noted by the clinician among the four groups (6/17 patients, 5/15, 4/21, 2/15; X2=3-00, df= 3, p>O0 1). When compared with the control group the three treatment groups were found to be very similar in terms of sun exposure, except that slightly fewer patients taking prednisolone were in the high exposure group (NS). The degree of solar elastosis was also similar in all four groups (table III) .
Discussion
In this study treatment with high dose inhaled corticosteroids was associated with skin thinning and increased purpura. This phenomenon is supported by clinical observations elsewhere in Britain, including two reports to the Committee on Safety of Medicines (S Wood, personal communication, 1989). There were no commensurate differences in solar exposure and the changes were equally apparent in sites not exposed to the sun. The four groups of patients were also similar in age. As there is a consistent relation between male and female skin thickness" we were able to apply a correction factor to overcome the difference. With use of the adjusted data the non-parametric tests showed significant differences in skin thickness at all sites in the high dose inhaled corticosteroid and systemic steroid treated groups.
There are potential problems inherent in all cross sectional studies of patients with asthma. The corticosteroid treatment given to the individual patients in this study was determined on clinical criteria only, reducing comparability among the four groups. Furthermore, as in the assessment of bone mass'7 the possible confounding influence of previous short courses of prednisolone must be considered.'1 Such treatment is a cornerstone in the management of patients with chronic severe asthma. Thus it is extremely difficult to find patients for study who are taking high dose inhaled corticosteroids and have not at some time had short courses of prednisolone. The median lifetime dose of prednisolone was only 200 mg in the 21 patients using high dose inhaled corticosteroids, and none had received short courses of prednisolone within the preceding six months. It remains possible that the skin changes seen with high dose inhaled corticosteroids may also reflect a synergistic effect of previous courses of prednisolone.
Dermal thinning may be measured by xeroradiography, skinfold callipers, biopsy, or ultrasound." 19 Pulsed A scan ultrasound is rapid, non-invasive, reproducible, and sensitive and will detect dermal thinning within days of the patient beginning topical corticosteroids." 12 1920 Results correlate highly with those of xeroradiography and epidermal biopsy. 2' It is well known that topical or systemic corticosteroids can produce both macroscopic and microscopic skin changes. Clinically the skin becomes thin, fragile, and transparent with loss of subcutaneous tissue, increased mobility, and purpura-"blot haemorrhages."2' 22 The skin is less resistant to trauma, and trivial injuries may cause surprisingly extensive tears.2524 Cutaneous atrophy with systemic treatment tends to be dose related and is more common in older patients after prolonged use of prednisolone or triamcinolone acetonide.21 2 Effects similar to those caused by topical and systemic corticosteroids were seen in patients taking high dose inhaled corticosteroids, presumably from systemic absorption. There is a growing awareness that high dose inhaled corticosteroids may cause a variety of systemic effects. Results-In the 127 children for whom adequate information was available ears in which a grommet had been inserted performed better in the short term (for at least six months) than those in which no grommet had been inserted, irrespective of any accompanying procedure. Most of the benefit had disappeared by 12 months. Adenoidectomy produced a slight improvement that was not significant, though was sustained for at least two years. The ears of children who had had an adenoidectomy with myringotomy and grommet insertion, however, continued to improve so that two years after surgery about 50% had abnormal tympanometry compared with 83% of those who had had only myringotomy and grommet insertion, and 93% of the group that had had no treatment. Logistic regression analyses identified preoperative hearing level as the single best predictor of good outcome from surgery. Other variables contributed little additional predictive power.
Conclusions-If the principal objective of surgery for glue ear is to restore hearing then our study shows that insertion of grommets is the treatment of choice. The addition of an adenoidectomy will increase the likelihood of restoration of normal function of the middle ear but will not improve hearing. When deciding appropriate indications for surgery, a balance has to be made between performing unnecessary operations and failing to treat patients who might benefit from surgical intervention. Preoperative audiometry scores might be the best predictor in helping to make this decision.
Introduction
Glue ear, or otitis media with effusion, is the commonest reason for elective surgery 16 Secondly, myringotomy plus grommet insertion is effective for up to 12 months,2 3 though two studies found that this procedure was not
